Literature DB >> 21423251

Prevention of catheter-related bloodstream infection in patients on hemodialysis.

Michiel G H Betjes1.   

Abstract

Central venous catheters (CVCs) are frequently used as vascular access for patients who require hemodialysis, but infectious complications remain a major clinical problem. Specifically, catheter-related bloodstream infections (CRBSIs) have an adverse effect on survival, hospitalization, mortality, and the overall cost of care in this setting. The growing number of patients who require hemodialysis, combined with an increasing number of patients who cannot use any vascular access other than a CVC, stress the importance of strategies to prevent CRBSI. Various interventions aimed at reducing the incidence of CRBSI are available, but they have not yet been integrated into evidence-based, consensus guidelines. In this Review, the results from several CVC infection prevention studies-of patients from dialysis and nondialysis settings-are combined to outline a rational approach to CRBSI prevention. Prevention of intraluminal contamination of the CVC is pivotal and of proven efficacy, as are strict aseptic CVC insertion and handling protocols, use of chlorhexidine in alcohol solutions for skin cleansing, topical application of antimicrobial ointments, and antimicrobial lock solutions. Adherence to a meticulous catheter care protocol can achieve a CRBSI incidence well below one episode per 1,000 catheter days, even without the need for antimicrobial ointments or lock solutions.

Entities:  

Mesh:

Year:  2011        PMID: 21423251     DOI: 10.1038/nrneph.2011.28

Source DB:  PubMed          Journal:  Nat Rev Nephrol        ISSN: 1759-5061            Impact factor:   28.314


  96 in total

1.  Why is it that internists do not follow guidelines for preventing intravascular catheter infections?

Authors:  Lewis Rubinson; Albert W Wu; Edward E Haponik; Gregory B Diette
Journal:  Infect Control Hosp Epidemiol       Date:  2005-06       Impact factor: 3.254

2.  Interventions to decrease catheter-related bloodstream infections in the ICU: the Keystone Intensive Care Unit Project.

Authors:  Peter Pronovost
Journal:  Am J Infect Control       Date:  2008-12       Impact factor: 2.918

3.  Locking solutions for hemodialysis catheters; heparin and citrate--a position paper by ASDIN.

Authors:  John E Moran; Stephen R Ash
Journal:  Semin Dial       Date:  2008-08-29       Impact factor: 3.455

4.  Guidelines for the prevention of intravascular catheter-related infections. Centers for Disease Control and Prevention.

Authors:  Naomi P O'Grady; Mary Alexander; E Patchen Dellinger; Julie L Gerberding; Stephen O Heard; Dennis G Maki; Henry Masur; Rita D McCormick; Leonard A Mermel; Michele L Pearson; Issam I Raad; Adrienne Randolph; Robert A Weinstein
Journal:  MMWR Recomm Rep       Date:  2002-08-09

5.  Antibiotic-coated hemodialysis catheters for the prevention of vascular catheter-related infections: a prospective, randomized study.

Authors:  Ioannis Chatzinikolaou; Kevin Finkel; Hend Hanna; Maha Boktour; John Foringer; Tam Ho; Issam Raad
Journal:  Am J Med       Date:  2003-10-01       Impact factor: 4.965

6.  Prevention of central venous catheter-related infections by using maximal sterile barrier precautions during insertion.

Authors:  I I Raad; D C Hohn; B J Gilbreath; N Suleiman; L A Hill; P A Bruso; K Marts; P F Mansfield; G P Bodey
Journal:  Infect Control Hosp Epidemiol       Date:  1994-04       Impact factor: 3.254

Review 7.  Effectiveness of impregnated central venous catheters for catheter related blood stream infection: a systematic review.

Authors:  Ruth E Gilbert; Melissa Harden
Journal:  Curr Opin Infect Dis       Date:  2008-06       Impact factor: 4.915

8.  Nasal mupirocin ointment decreases the incidence of Staphylococcus aureus bacteraemias in haemodialysis patients.

Authors:  J R Boelaert; H W Van Landuyt; C A Godard; R F Daneels; M L Schurgers; E G Matthys; Y A De Baere; D W Gheyle; B Z Gordts; L A Herwaldt
Journal:  Nephrol Dial Transplant       Date:  1993       Impact factor: 5.992

9.  Femoral vs jugular venous catheterization and risk of nosocomial events in adults requiring acute renal replacement therapy: a randomized controlled trial.

Authors:  Jean-Jacques Parienti; Marina Thirion; Bruno Mégarbane; Bertrand Souweine; Abdelali Ouchikhe; Andrea Polito; Jean-Marie Forel; Sophie Marqué; Benoît Misset; Norair Airapetian; Claire Daurel; Jean-Paul Mira; Michel Ramakers; Damien du Cheyron; Xavier Le Coutour; Cédric Daubin; Pierre Charbonneau
Journal:  JAMA       Date:  2008-05-28       Impact factor: 56.272

10.  Risk factor analysis for long-term tunneled dialysis catheter-related bacteremias.

Authors:  G Jean; B Charra; C Chazot; T Vanel; J C Terrat; J M Hurot; G Laurent
Journal:  Nephron       Date:  2002-07       Impact factor: 2.847

View more
  14 in total

1.  Microbiology of Non-Tunnelled Catheter-Related Infections.

Authors:  Shefali Gupta; Shrikara P Mallya; Ashok Bhat; Shrikala Baliga
Journal:  J Clin Diagn Res       Date:  2016-07-01

2.  Complications of intravascular catheters in ICU: definitions, incidence and severity. A randomized controlled trial comparing usual transparent dressings versus new-generation dressings (the ADVANCED study).

Authors:  Silvia Calviño Günther; Carole Schwebel; Rebecca Hamidfar-Roy; Agnès Bonadona; Maxime Lugosi; Claire Ara-Somohano; Clémence Minet; Leïla Potton; Jean-Charles Cartier; Aurelien Vésin; Magalie Chautemps; Lenka Styfalova; Stephane Ruckly; Jean-François Timsit
Journal:  Intensive Care Med       Date:  2016-10-12       Impact factor: 17.440

Review 3.  Infectious complications in dialysis--epidemiology and outcomes.

Authors:  Philip Kam-Tao Li; Kai Ming Chow
Journal:  Nat Rev Nephrol       Date:  2011-12-20       Impact factor: 28.314

4.  An organoselenium compound inhibits Staphylococcus aureus biofilms on hemodialysis catheters in vivo.

Authors:  Phat L Tran; Nathan Lowry; Thomas Campbell; Ted W Reid; Daniel R Webster; Eric Tobin; Arash Aslani; Thomas Mosley; Janet Dertien; Jane A Colmer-Hamood; Abdul N Hamood
Journal:  Antimicrob Agents Chemother       Date:  2011-11-28       Impact factor: 5.191

Review 5.  Ethanol lock is effective on reducing the incidence of tunneled catheter-related bloodstream infections in hemodialysis patients: a systematic review and meta-analysis.

Authors:  Tingting Zhao; Hong Liu; Jibin Han
Journal:  Int Urol Nephrol       Date:  2018-04-17       Impact factor: 2.370

6.  Comparative effectiveness of 30 % trisodium citrate and heparin lock solution in preventing infection and dysfunction of hemodialysis catheters: a randomized controlled trial (CITRIM trial).

Authors:  Franklin Correa Barcellos; Bruno Pereira Nunes; Luciana Jorge Valle; Thiago Lopes; Bianca Orlando; Cintia Scherer; Marcia Nunes; Gabriela Araújo Duarte; Maristela Böhlke
Journal:  Infection       Date:  2016-08-29       Impact factor: 3.553

7.  Successful prevention of tunneled central catheter infection by antibiotic lock therapy using cefazolin and gentamicin.

Authors:  T N V Silva; M L Mendes; J M G Abrão; J T Caramori; D Ponce
Journal:  Int Urol Nephrol       Date:  2012-12-27       Impact factor: 2.370

8.  Ethanol lock therapy (E-Lock) in the prevention of catheter-related bloodstream infections (CR-BSI) after major heart surgery (MHS): a randomized clinical trial.

Authors:  María Jesús Pérez-Granda; José María Barrio; Patricia Muñoz; Javier Hortal; Cristina Rincón; Pablo Martin Rabadán; Maria Sagrario Pernia; Emilio Bouza
Journal:  PLoS One       Date:  2014-03-27       Impact factor: 3.240

Review 9.  Antimicrobial lock solutions for preventing catheter-related infections in haemodialysis.

Authors:  Maria C Arechabala; Maria I Catoni; Juan Carlos Claro; Noelia P Rojas; Miriam E Rubio; Mario A Calvo; Luz M Letelier
Journal:  Cochrane Database Syst Rev       Date:  2018-04-03

10.  Association between acetylsalicylic acid and the risk of dialysis-related infections or septicemia among incident hemodialysis patients: a nested case-control study.

Authors:  Hind Harrak; Isabelle Normand; Rachel Grinker; Naoual Elftouh; Louis-Philippe Laurin; Jean-Philippe Lafrance
Journal:  BMC Nephrol       Date:  2015-07-28       Impact factor: 2.388

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.